Literature DB >> 3006678

Redistribution of protein kinase C during mitogenesis of human B lymphocytes.

G R Guy, J Gordon, L Walker, R H Michell, G Brown.   

Abstract

G0 human tonsillar B-lymphocytes were stimulated to divide by the polyclonal mitogen Staphylococcus Aureus Cowan strain 1 (SAC) and by the combined use of 12-O-tetradecanoyl phorbol-13-acetate (TPA) and the calcium ionophore ionomycin. The activities of protein kinase C, which requires Ca++ and phospholipid as co-factors, and a proteolytically cleaved form of this enzyme (protein kinase M), which is independent of calcium and phospholipid control, were determined in soluble and particulate fractions obtained from activated B cells. Treatment of G0 B cells with SAC or TPA together with ionomycin caused redistribution of protein kinase C from the soluble to the particulate fraction where the 80,000-Dalton protein kinase C was cleaved to give rise to a 50,000-Dalton form of the kinase which was also found in the cytoplasm. These data suggest that redistribution and proteolytic cleavage of protein kinase C are key signal transduction events in B cell mitogenesis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3006678     DOI: 10.1016/0006-291x(86)90954-x

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

Review 1.  Membrane Ig-mediated triggering of B cell tolerance and B cell clonal expansion: implications for rheumatoid factor production in rheumatoid synovitis.

Authors:  P K Mongini; S M Rudich
Journal:  Springer Semin Immunopathol       Date:  1989

Review 2.  Calcium, cyclic AMP and protein kinase C--partners in mitogenesis.

Authors:  J F Whitfield; J P Durkin; D J Franks; L P Kleine; L Raptis; R H Rixon; M Sikorska; P R Walker
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

3.  Induction of EL4 cell resistance to syngeneic macrophage-mediated lysis by protein kinase C ligands; effects of cultured TPA-treated target cell and protein phosphorylation.

Authors:  N Essani; M Fishman
Journal:  Immunology       Date:  1988-10       Impact factor: 7.397

4.  An anti-platelet agent, OPC-29030, inhibits translocation of 12-lipoxygenase and 12-hydroxyeicosatetraenoic acid production in human platelets.

Authors:  Y Ozeki; Y Nagamura; H Ito; F Unemi; Y Kimura; T Igawa; J i Kambayashi; Y Takahashi; T Yoshimoto
Journal:  Br J Pharmacol       Date:  1999-12       Impact factor: 8.739

5.  Vanadate normalizes hyperglycemia in two mouse models of non-insulin-dependent diabetes mellitus.

Authors:  J Meyerovitch; P Rothenberg; Y Shechter; S Bonner-Weir; C R Kahn
Journal:  J Clin Invest       Date:  1991-04       Impact factor: 14.808

6.  Hepatic phosphotyrosine phosphatase activity and its alterations in diabetic rats.

Authors:  J Meyerovitch; J M Backer; C R Kahn
Journal:  J Clin Invest       Date:  1989-09       Impact factor: 14.808

7.  Inhibition by glucocorticoid and staurosporine of IL-4-dependent CD23 production in B lymphocytes is reversed on engaging CD40.

Authors:  A Katira; K A Knox; M Finney; R H Michell; M Wakelam; J Gordon
Journal:  Clin Exp Immunol       Date:  1993-05       Impact factor: 4.330

8.  Effects of the constitutively active proteolytic fragment of protein kinase C on the contractile properties of demembranated smooth muscle fibres.

Authors:  J E Parente; M P Walsh; W G Kerrick; P E Hoar
Journal:  J Muscle Res Cell Motil       Date:  1992-02       Impact factor: 2.698

9.  Immunological evidence for two physiological forms of protein kinase C.

Authors:  J R Woodgett; T Hunter
Journal:  Mol Cell Biol       Date:  1987-01       Impact factor: 4.272

10.  Cytoplasmic [Ca2+] and intracellular pH in lymphocytes. Role of membrane potential and volume-activated Na+/H+ exchange.

Authors:  S Grinstein; S Cohen
Journal:  J Gen Physiol       Date:  1987-02       Impact factor: 4.086

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.